Skip to search formSkip to main contentSkip to account menu

250 ML sipuleucel-T 200000 CELLS/ML Injection

Known as: SIPULEUCEL-T/LR SUSP INJ 250ML, SIPULEUCEL-T/LACTATED RINGERS INJ,SUSP,250ML [VA Product], sipuleucel-T 50,000,000 CELLS per 250 ML Injection 
National Institutes of Health

Related topics

Related topics

6 relations

Narrower (1)

250 ML sipuleucel-T 200000 CELLS/ML Injection [Provenge]

Broader (2)

IMMUNE STIMULANTSsipuleucel-T Injection
InjectionPeripheral blood mononuclear cell (cell)sipuleucel-T

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Pharmaco-economic aspects of Sipuleucel-T
Sipuleucel-T, a new autologous active cellular immunotherapy, is indicated for metastatic castration-resistant prostate cancer… 
Review
2012
Review
2012
Therapie des kastrationsrefraktären Prostatakarzinoms
ZusammenfassungInnerhalb der letzten zwei Jahre hat die Therapie des kastrationsrefraktären Prostatakarzinoms (CRPC) große… 
2011
2011
Unintended consequences--the cost of preventing preterm births after FDA approval of a branded version of 17OHP.
The recent approval by the Food and Drug Administration of Makena, a new version of progesterone 17 alpha-hydroxyprogesterone… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)